CN Stock MarketDetailed Quotes

688163 Shanghai Serum Bio-Technology

Watchlist
  • 15.40
  • -0.05-0.32%
Market Closed Sep 11 15:00 CST
1.67BMarket Cap37.75P/E (TTM)

Shanghai Serum Bio-Technology Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
Total operating revenue
4.58%98.06M
9.79%26.3M
9.14%190.14M
11.17%166.13M
19.88%93.76M
-3.80%23.96M
-16.52%174.22M
-11.04%149.43M
-18.46%78.21M
12.04%24.9M
Operating revenue
4.58%98.06M
9.79%26.3M
9.14%190.14M
11.17%166.13M
19.88%93.76M
-3.80%23.96M
-16.52%174.22M
-11.04%149.43M
-18.46%78.21M
12.04%24.9M
Total operating cost
1.86%68.03M
17.63%28.35M
29.48%150.18M
27.56%111.75M
34.43%66.79M
13.69%24.1M
-6.04%115.98M
2.56%87.61M
-1.68%49.68M
12.74%21.2M
Operating cost
-1.66%22.98M
2.85%7.51M
63.34%46.19M
63.72%38.34M
98.75%23.37M
73.91%7.3M
-16.97%28.28M
-11.64%23.42M
-22.70%11.76M
8.31%4.2M
Operating tax surcharges
5.34%796.69K
11.67%326.14K
26.89%1.53M
16.56%1.21M
10.57%756.3K
-39.43%292.05K
-16.84%1.21M
-6.13%1.04M
-0.20%684.03K
89.84%482.21K
Operating expense
-9.39%22.28M
-2.92%9.58M
7.10%53.84M
1.10%36.98M
22.31%24.59M
3.53%9.87M
15.84%50.27M
27.47%36.58M
25.60%20.1M
46.08%9.53M
Administration expense
-1.11%10.49M
26.74%5.25M
-12.49%20.51M
-22.47%15.02M
-19.40%10.61M
-6.45%4.14M
20.74%23.44M
32.57%19.37M
57.03%13.17M
6.45%4.42M
Financial expense
40.39%-919.05K
33.72%-512.43K
13.59%-2.31M
18.20%-1.91M
15.40%-1.54M
11.34%-773.14K
-319.29%-2.67M
-402.84%-2.34M
-495.67%-1.82M
-85.90%-872.06K
-Interest expense (Financial expense)
-5.08%311.59K
-5.08%155.79K
-4.73%648.26K
-4.70%488.25K
-4.63%328.25K
-4.63%164.12K
-4.24%680.46K
-4.17%512.31K
-4.05%344.16K
-4.05%172.08K
-Interest Income (Financial expense)
25.95%-1.22M
33.71%-657.73K
-0.37%-2.88M
1.21%-2.23M
12.80%-1.65M
3.27%-992.25K
-93.37%-2.87M
-116.15%-2.26M
-161.07%-1.89M
-134.81%-1.03M
Research and development
37.72%12.4M
89.35%6.2M
96.75%30.41M
131.84%22.11M
55.46%9M
-4.65%3.28M
-40.00%15.46M
-36.28%9.54M
-45.10%5.79M
-22.98%3.44M
Credit Impairment Loss
34.82%-1.67M
-278.74%-637.25K
-289.79%-997.07K
-2,066.27%-1.98M
-314.39%-2.56M
148.79%356.53K
187.37%525.35K
87.60%-91.4K
71.10%-616.94K
-268.27%-730.81K
Asset Impairment Loss
58.08%-907.99K
66.22%-365.01K
30.04%-3.65M
4.04%-2.86M
-10.32%-2.17M
-185.04%-1.08M
-129.69%-5.22M
-43.86%-2.98M
-31.47%-1.96M
49.38%1.27M
Other net revenue
Fair value change income
-48.59%1.97M
37.44%2.26M
-0.95%2.59M
-3.58%3.12M
57.64%3.84M
618.75%1.64M
1,657.53%2.62M
1,339.55%3.24M
1,415.09%2.44M
147.56%228.75K
Invest income
6.95%4.36M
-75.74%645.46K
-42.32%7.74M
-29.99%5.97M
-1.76%4.07M
3,379.76%2.66M
1,534.66%13.43M
1,240.96%8.53M
695.53%4.15M
83.06%-81.14K
-Including: Investment income associates
12.41%-1.7M
-68.36%-990.43K
-198.38%-7.35M
-257.46%-5.36M
-386.76%-1.94M
-47.79%-588.29K
8.73%-2.46M
10.60%-1.5M
63.57%-397.7K
33.14%-398.07K
Asset deal income
----
----
----
----
--11.92K
----
----
----
----
----
Other revenue
1,377.01%3.45M
1,160.60%2.08M
-93.47%331.53K
-91.65%248.16K
-91.89%233.53K
327.17%164.75K
-23.28%5.08M
-34.63%2.97M
-18.16%2.88M
-90.24%38.57K
Operating profit
22.44%37.23M
-46.31%1.94M
-38.41%45.98M
-19.88%58.88M
-14.12%30.41M
-18.68%3.6M
-15.36%74.66M
-12.26%73.49M
-20.86%35.41M
8.45%4.43M
Add:Non operating Income
10,630,000.00%1.06K
----
-81.99%13.15K
-81.99%13.15K
-100.00%0.01
----
-27.44%73K
--73K
--73K
----
Less:Non operating expense
274.76%179.14K
--19.1K
-16.52%581.86K
-59.54%163.22K
-70.12%47.8K
----
61.00%697.02K
23.46%403.4K
-25.27%160K
-93.94%10K
Total profit
22.04%37.05M
-46.84%1.92M
-38.66%45.42M
-19.72%58.73M
-14.05%30.36M
-18.50%3.6M
-15.75%74.04M
-12.31%73.16M
-20.68%35.32M
12.47%4.42M
Less:Income tax cost
37.47%4.75M
-25.12%441.49K
-32.51%6.64M
-23.63%7.94M
-28.98%3.45M
27.39%589.63K
-13.64%9.84M
-7.85%10.39M
-11.57%4.86M
-10.07%462.87K
Net profit
20.06%32.31M
-51.09%1.47M
-39.60%38.77M
-19.07%50.8M
-11.67%26.91M
-23.86%3.02M
-16.06%64.2M
-13.01%62.77M
-21.96%30.46M
15.87%3.96M
Net profit from continuing operation
20.06%32.31M
-51.09%1.47M
-39.60%38.77M
-19.07%50.8M
-11.67%26.91M
-23.86%3.02M
-16.06%64.2M
-13.01%62.77M
-21.96%30.46M
15.87%3.96M
Net profit of parent company owners
20.06%32.31M
-51.09%1.47M
-39.60%38.77M
-19.07%50.8M
-11.67%26.91M
-23.86%3.02M
-16.06%64.2M
-13.01%62.77M
-21.96%30.46M
15.87%3.96M
Earning per share
Basic earning per share
20.00%0.3
-66.67%0.01
-42.86%0.36
-25.40%0.47
-21.88%0.25
-25.00%0.03
-32.98%0.63
-29.21%0.63
-33.33%0.32
0.00%0.04
Diluted earning per share
20.00%0.3
-66.67%0.01
-42.86%0.36
-25.40%0.47
-21.88%0.25
-25.00%0.03
-32.98%0.63
-29.21%0.63
-33.33%0.32
0.00%0.04
Other composite income
Total composite income
20.06%32.31M
-51.09%1.47M
-39.60%38.77M
-19.07%50.8M
-11.67%26.91M
-23.86%3.02M
-16.06%64.2M
-13.01%62.77M
-21.96%30.46M
15.87%3.96M
Total composite income of parent company owners
20.06%32.31M
-51.09%1.47M
-39.60%38.77M
-19.07%50.8M
-11.67%26.91M
-23.86%3.02M
-16.06%64.2M
-13.01%62.77M
-21.96%30.46M
15.87%3.96M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
Unqualified opinion
--
--
--
--
--
--
--
Auditor
--
--
Tianzhu International Accounting Firm (Special General Partnership)
--
--
--
Tianzhu International Accounting Firm (Special General Partnership)
--
--
--
(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022
Total operating revenue 4.58%98.06M9.79%26.3M9.14%190.14M11.17%166.13M19.88%93.76M-3.80%23.96M-16.52%174.22M-11.04%149.43M-18.46%78.21M12.04%24.9M
Operating revenue 4.58%98.06M9.79%26.3M9.14%190.14M11.17%166.13M19.88%93.76M-3.80%23.96M-16.52%174.22M-11.04%149.43M-18.46%78.21M12.04%24.9M
Total operating cost 1.86%68.03M17.63%28.35M29.48%150.18M27.56%111.75M34.43%66.79M13.69%24.1M-6.04%115.98M2.56%87.61M-1.68%49.68M12.74%21.2M
Operating cost -1.66%22.98M2.85%7.51M63.34%46.19M63.72%38.34M98.75%23.37M73.91%7.3M-16.97%28.28M-11.64%23.42M-22.70%11.76M8.31%4.2M
Operating tax surcharges 5.34%796.69K11.67%326.14K26.89%1.53M16.56%1.21M10.57%756.3K-39.43%292.05K-16.84%1.21M-6.13%1.04M-0.20%684.03K89.84%482.21K
Operating expense -9.39%22.28M-2.92%9.58M7.10%53.84M1.10%36.98M22.31%24.59M3.53%9.87M15.84%50.27M27.47%36.58M25.60%20.1M46.08%9.53M
Administration expense -1.11%10.49M26.74%5.25M-12.49%20.51M-22.47%15.02M-19.40%10.61M-6.45%4.14M20.74%23.44M32.57%19.37M57.03%13.17M6.45%4.42M
Financial expense 40.39%-919.05K33.72%-512.43K13.59%-2.31M18.20%-1.91M15.40%-1.54M11.34%-773.14K-319.29%-2.67M-402.84%-2.34M-495.67%-1.82M-85.90%-872.06K
-Interest expense (Financial expense) -5.08%311.59K-5.08%155.79K-4.73%648.26K-4.70%488.25K-4.63%328.25K-4.63%164.12K-4.24%680.46K-4.17%512.31K-4.05%344.16K-4.05%172.08K
-Interest Income (Financial expense) 25.95%-1.22M33.71%-657.73K-0.37%-2.88M1.21%-2.23M12.80%-1.65M3.27%-992.25K-93.37%-2.87M-116.15%-2.26M-161.07%-1.89M-134.81%-1.03M
Research and development 37.72%12.4M89.35%6.2M96.75%30.41M131.84%22.11M55.46%9M-4.65%3.28M-40.00%15.46M-36.28%9.54M-45.10%5.79M-22.98%3.44M
Credit Impairment Loss 34.82%-1.67M-278.74%-637.25K-289.79%-997.07K-2,066.27%-1.98M-314.39%-2.56M148.79%356.53K187.37%525.35K87.60%-91.4K71.10%-616.94K-268.27%-730.81K
Asset Impairment Loss 58.08%-907.99K66.22%-365.01K30.04%-3.65M4.04%-2.86M-10.32%-2.17M-185.04%-1.08M-129.69%-5.22M-43.86%-2.98M-31.47%-1.96M49.38%1.27M
Other net revenue
Fair value change income -48.59%1.97M37.44%2.26M-0.95%2.59M-3.58%3.12M57.64%3.84M618.75%1.64M1,657.53%2.62M1,339.55%3.24M1,415.09%2.44M147.56%228.75K
Invest income 6.95%4.36M-75.74%645.46K-42.32%7.74M-29.99%5.97M-1.76%4.07M3,379.76%2.66M1,534.66%13.43M1,240.96%8.53M695.53%4.15M83.06%-81.14K
-Including: Investment income associates 12.41%-1.7M-68.36%-990.43K-198.38%-7.35M-257.46%-5.36M-386.76%-1.94M-47.79%-588.29K8.73%-2.46M10.60%-1.5M63.57%-397.7K33.14%-398.07K
Asset deal income ------------------11.92K--------------------
Other revenue 1,377.01%3.45M1,160.60%2.08M-93.47%331.53K-91.65%248.16K-91.89%233.53K327.17%164.75K-23.28%5.08M-34.63%2.97M-18.16%2.88M-90.24%38.57K
Operating profit 22.44%37.23M-46.31%1.94M-38.41%45.98M-19.88%58.88M-14.12%30.41M-18.68%3.6M-15.36%74.66M-12.26%73.49M-20.86%35.41M8.45%4.43M
Add:Non operating Income 10,630,000.00%1.06K-----81.99%13.15K-81.99%13.15K-100.00%0.01-----27.44%73K--73K--73K----
Less:Non operating expense 274.76%179.14K--19.1K-16.52%581.86K-59.54%163.22K-70.12%47.8K----61.00%697.02K23.46%403.4K-25.27%160K-93.94%10K
Total profit 22.04%37.05M-46.84%1.92M-38.66%45.42M-19.72%58.73M-14.05%30.36M-18.50%3.6M-15.75%74.04M-12.31%73.16M-20.68%35.32M12.47%4.42M
Less:Income tax cost 37.47%4.75M-25.12%441.49K-32.51%6.64M-23.63%7.94M-28.98%3.45M27.39%589.63K-13.64%9.84M-7.85%10.39M-11.57%4.86M-10.07%462.87K
Net profit 20.06%32.31M-51.09%1.47M-39.60%38.77M-19.07%50.8M-11.67%26.91M-23.86%3.02M-16.06%64.2M-13.01%62.77M-21.96%30.46M15.87%3.96M
Net profit from continuing operation 20.06%32.31M-51.09%1.47M-39.60%38.77M-19.07%50.8M-11.67%26.91M-23.86%3.02M-16.06%64.2M-13.01%62.77M-21.96%30.46M15.87%3.96M
Net profit of parent company owners 20.06%32.31M-51.09%1.47M-39.60%38.77M-19.07%50.8M-11.67%26.91M-23.86%3.02M-16.06%64.2M-13.01%62.77M-21.96%30.46M15.87%3.96M
Earning per share
Basic earning per share 20.00%0.3-66.67%0.01-42.86%0.36-25.40%0.47-21.88%0.25-25.00%0.03-32.98%0.63-29.21%0.63-33.33%0.320.00%0.04
Diluted earning per share 20.00%0.3-66.67%0.01-42.86%0.36-25.40%0.47-21.88%0.25-25.00%0.03-32.98%0.63-29.21%0.63-33.33%0.320.00%0.04
Other composite income
Total composite income 20.06%32.31M-51.09%1.47M-39.60%38.77M-19.07%50.8M-11.67%26.91M-23.86%3.02M-16.06%64.2M-13.01%62.77M-21.96%30.46M15.87%3.96M
Total composite income of parent company owners 20.06%32.31M-51.09%1.47M-39.60%38.77M-19.07%50.8M-11.67%26.91M-23.86%3.02M-16.06%64.2M-13.01%62.77M-21.96%30.46M15.87%3.96M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ----Unqualified opinion--------------
Auditor ----Tianzhu International Accounting Firm (Special General Partnership)------Tianzhu International Accounting Firm (Special General Partnership)------

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg